These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 36056210)
1. Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemia. Tang B; Cai Z; Wang Z; Lin D; He X; Li Q; Liang X; Huang K; Zhou X; Lin R; Xu N; Fan Z; Huang F; Sun J; Liu X; Liu Q; Zhou H Bone Marrow Transplant; 2022 Dec; 57(12):1751-1757. PubMed ID: 36056210 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of IKZF1 gene deletions in patients with B-cell acute lymphoblastic leukemia]. Tang BQ; Cai ZH; Lin DN; Wang ZX; Liang XJ; Fan ZP; Huang F; Liu QF; Zhou HS Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):235-240. PubMed ID: 35405782 [No Abstract] [Full Text] [Related]
3. Prognostic significance and treatment strategies for IKZF1 deletion in pediatric B-cell precursor acute lymphoblastic leukemia. Pan L; Chen Y; Weng K; Guo B; Zhuang S; Huang S; Lian Z; Wang X; Li N; Zheng Y BMC Cancer; 2024 Aug; 24(1):1070. PubMed ID: 39210321 [TBL] [Abstract][Full Text] [Related]
4. Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. Tang S; Shen H; Qu C; Dai H; Zhu X; Xue S; Ding Z; Lu J; Wu D; Tang X Bone Marrow Transplant; 2019 Feb; 54(2):236-243. PubMed ID: 29942002 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of IKZF1 Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444 [TBL] [Abstract][Full Text] [Related]
6. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951. Clappier E; Grardel N; Bakkus M; Rapion J; De Moerloose B; Kastner P; Caye A; Vivent J; Costa V; Ferster A; Lutz P; Mazingue F; Millot F; Plantaz D; Plat G; Plouvier E; Poirée M; Sirvent N; Uyttebroeck A; Yakouben K; Girard S; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H; Leukemia; 2015 Nov; 29(11):2154-61. PubMed ID: 26050650 [TBL] [Abstract][Full Text] [Related]
7. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. Asai D; Imamura T; Suenobu S; Saito A; Hasegawa D; Deguchi T; Hashii Y; Matsumoto K; Kawasaki H; Hori H; Iguchi A; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Oda M; Cancer Med; 2013 Jun; 2(3):412-9. PubMed ID: 23930217 [TBL] [Abstract][Full Text] [Related]
8. Combined analysis of Cui L; Gao C; Wang CJ; Zhao XX; Li WJ; Li ZG; Zheng HY; Wang TY; Zhang RD Leuk Lymphoma; 2021 Feb; 62(2):410-418. PubMed ID: 33054468 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of IKZF1 deletions and IKZF1 Braun M; Pastorczak A; Sędek Ł; Taha J; Madzio J; Jatczak-Pawlik I; Wypyszczak K; Matysiak M; Derwich K; Lejman M; Kazanowska B; Szczepański T; Kowalczyk JR; Mlynarski W; Hematol Oncol; 2022 Aug; 40(3):430-441. PubMed ID: 35118711 [TBL] [Abstract][Full Text] [Related]
10. Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. Mangum DS; Meyer JA; Mason CC; Shams S; Maese LD; Gardiner JD; Downie JM; Pei D; Cheng C; Gleason A; Luo M; Pui CH; Aplenc R; Hunger SP; Loh M; Greaves M; Trede N; Raetz E; Frazer JK; Mullighan CG; Engel ME; Miles RR; Rabin KR; Schiffman JD JAMA Oncol; 2021 Oct; 7(10):1521-1528. PubMed ID: 34410295 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia: higher levels are associated with a poorer prognosis. Huang Z; Jia Y; Ruan G; Zuo Y; Wu J; Lu A; Xue Y; Cheng Y; Zhang L Pediatr Hematol Oncol; 2022 Apr; 39(3):243-253. PubMed ID: 34582325 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study. Lin S; Liao N; Li X; Yang L; He YY; Tang YL; Wan WQ; Jia W; Zhang YJ; Kong Q; Long X; Lan X; Ling YY; Lin D; Zhang XL; Wen C; Li CK; Xu HG Eur J Haematol; 2024 Sep; 113(3):357-370. PubMed ID: 38847134 [TBL] [Abstract][Full Text] [Related]
13. PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia. Bedics G; Egyed B; Kotmayer L; Benard-Slagter A; de Groot K; Bekő A; Hegyi LL; Bátai B; Krizsán S; Kriván G; Erdélyi DJ; Müller J; Haltrich I; Kajtár B; Pajor L; Vojcek Á; Ottóffy G; Ujfalusi A; Szegedi I; Tiszlavicz LG; Bartyik K; Csanádi K; Péter G; Simon R; Hauser P; Kelemen Á; Sebestyén E; Jakab Z; Matolcsy A; Kiss C; Kovács G; Savola S; Bödör C; Alpár D Br J Cancer; 2023 Aug; 129(3):455-465. PubMed ID: 37340093 [TBL] [Abstract][Full Text] [Related]
14. IKZF1 Deletion Subtyping and Outcome Analysis in BCR-ABL1-Negative Pediatric B-Cell Acute Lymphoblastic Leukemia: A Single-Institution Experience from North India. Gupta SK; Bakhshi S; Gupta R; Sharma P; Pushpam D; Sahoo RK; Kamal VK Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e666-e673. PubMed ID: 33906825 [TBL] [Abstract][Full Text] [Related]
15. IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia. Yamashita Y; Shimada A; Yamada T; Yamaji K; Hori T; Tsurusawa M; Watanabe A; Kikuta A; Asami K; Saito AM; Horibe K Pediatr Blood Cancer; 2013 Oct; 60(10):1587-92. PubMed ID: 23804397 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. Boer JM; van der Veer A; Rizopoulos D; Fiocco M; Sonneveld E; de Groot-Kruseman HA; Kuiper RP; Hoogerbrugge P; Horstmann M; Zaliova M; Palmi C; Trka J; Fronkova E; Emerenciano M; do Socorro Pombo-de-Oliveira M; Mlynarski W; Szczepanski T; Nebral K; Attarbaschi A; Venn N; Sutton R; Schwab CJ; Enshaei A; Vora A; Stanulla M; Schrappe M; Cazzaniga G; Conter V; Zimmermann M; Moorman AV; Pieters R; den Boer ML Leukemia; 2016 Jan; 30(1):32-8. PubMed ID: 26202931 [TBL] [Abstract][Full Text] [Related]
17. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. Clappier E; Auclerc MF; Rapion J; Bakkus M; Caye A; Khemiri A; Giroux C; Hernandez L; Kabongo E; Savola S; Leblanc T; Yakouben K; Plat G; Costa V; Ferster A; Girard S; Fenneteau O; Cayuela JM; Sigaux F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Soulier J; Cavé H Leukemia; 2014 Jan; 28(1):70-7. PubMed ID: 24064621 [TBL] [Abstract][Full Text] [Related]
18. [Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities]. Liu X; Zhang L; Zou Y; Chang L; Wei W; Ruan M; Chen Y; Yang W; Chen X; Guo Y; Wang S; Liu T; Zhang J; Liu F; Qi B; An W; Zhu X Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):126-30. PubMed ID: 26875463 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis. Zhang W; Kuang P; Li H; Wang F; Wang Y Ann Hematol; 2017 Feb; 96(2):215-225. PubMed ID: 27815723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]